TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Thern Medicine AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
1,304
|
1,797
|
1,215 |
| Financial expenses |
1
|
33
|
22 |
| Earnings before taxes |
-10
|
138
|
199 |
| EBITDA |
-307
|
105
|
231 |
| Total assets |
421
|
532
|
410 |
| Current assets |
399
|
407
|
282 |
| Current liabilities |
424
|
525
|
337 |
| Equity capital |
-3
|
7
|
73 |
| - share capital |
52
|
51
|
47 |
| Employees (average) |
2
|
2
|
2 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
-0.7%
|
1.3%
|
17.8% |
| Turnover per employee |
652
|
898
|
608 |
| Profit as a percentage of turnover |
-0.8%
|
7.7%
|
16.4% |
| Return on assets (ROA) |
-2.1%
|
32.1%
|
53.9% |
| Current ratio |
94.1%
|
77.5%
|
83.7% |
| Return on equity (ROE) |
333.3%
|
1971.4%
|
272.6% |
| Change turnover |
-526
|
495
|
980 |
| Change turnover % |
-29%
|
38%
|
416% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.